Skip to main content
XTLB logo

XTLB · Xtl Biopharmaceuticals Ltd

$2.96 +0.08 (+2.78%) At close · Jul 28
Market Cap
$7.27M
Shares
2.46M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 6
Total Value: $175,210
Total Shares: 72,702

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 6 13F filers · Δ vs Dec 31, 2025
Top Holder
68.4%
Jun 2023 → Mar 2026 · range 60.3% – 87.6%
+8.1 pts
Top 5
100.0%
Jun 2023 → Mar 2026 · range 99.5% – 100.0%
+0.5 pts
Top 10
100.0%
Jun 2023 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
5,104
Jun 2023 → Mar 2026 · range 4,276 – 7,759
Highly concentrated+828

Quarterly Activity

vs Dec 31, 2025
New
2
Increased
1
Decreased
2
Sold Out
2
Unchanged
1
Holder count: 0
Institutional value: -8.4%
Shares held: -78.0%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 6 of 6
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1023549 CUSIP 98386D406 Visit website